Related case:
TJD-AD 2022-017 Appeal Decision - Table Tennis
December 7, 2022
In August 2021 the Brazilian Doping Control Authority (ABCD) has reported an anti-doping rule violation against the paralympic table tennis player after his sample tested positive for the prohibited substances Androsterone, Etiocholanolone and Testosterone with its metabolites.
Following notification a provisional suspension was ordered. The Athlete filed a statement in his defence and the case was referred to the Brazilian Sports Justice Anti-Doping Tribunal (TJD-AD).
The Parathlete admitted the violation and denied the intentional use of the substances. He explained with evidence that he underwent prescribed medical treatment and had already applied for a retroactive TUE.
However the Athlete's TUE application was rejected and he acknowledged that he had acted negligently with this treatment. ABCD contended that he failed to demonstrate that the use of Testosterone was not intentional, neither was this a WADA approved treatment for his diagnosed condition.
The Rapporteur finds that the presence of the prohibited substances has been established in the Parathlete's sample and accordingly that he committed an anti-doping rule violation.
The Rapporteur concludes that the Athlete failed to demonstrate that the violation was not intentional, nor grounds for a reduced sanction. Further he considers that there had been substantial delays in the proceedings not attributed to the Parathlete.
Therefore the TJD-AD Panel decides on 14 June 2022 to impose a 4 year period of ineligibility on the Athlete, starting on the date of sample collection, i.e. on 23 February 2021.
